TGF-β Tumor Suppression through a Lethal EMT.

TitleTGF-β Tumor Suppression through a Lethal EMT.
Publication TypeJournal Article
Year of Publication2016
AuthorsDavid CJ, Huang Y-H, Chen M, Su J, Zou Y, Bardeesy N, Iacobuzio-Donahue CA, Massagué J
JournalCell
Volume164
Issue5
Pagination1015-30
Date Published2016 Feb 25
ISSN1097-4172
KeywordsAdenocarcinoma, Animals, Apoptosis, Carcinoma, Ductal, Epithelial-Mesenchymal Transition, Gene Regulatory Networks, Kruppel-Like Transcription Factors, Mice, Organoids, Pancreatic Neoplasms, Smad4 Protein, SOXC Transcription Factors, Transforming Growth Factor beta
Abstract

TGF-β signaling can be pro-tumorigenic or tumor suppressive. We investigated this duality in pancreatic ductal adenocarcinoma (PDA), which, with other gastrointestinal cancers, exhibits frequent inactivation of the TGF-β mediator Smad4. We show that TGF-β induces an epithelial-mesenchymal transition (EMT), generally considered a pro-tumorigenic event. However, in TGF-β-sensitive PDA cells, EMT becomes lethal by converting TGF-β-induced Sox4 from an enforcer of tumorigenesis into a promoter of apoptosis. This is the result of an EMT-linked remodeling of the cellular transcription factor landscape, including the repression of the gastrointestinal lineage-master regulator Klf5. Klf5 cooperates with Sox4 in oncogenesis and prevents Sox4-induced apoptosis. Smad4 is required for EMT but dispensable for Sox4 induction by TGF-β. TGF-β-induced Sox4 is thus geared to bolster progenitor identity, whereas simultaneous Smad4-dependent EMT strips Sox4 of an essential partner in oncogenesis. Our work demonstrates that TGF-β tumor suppression functions through an EMT-mediated disruption of a lineage-specific transcriptional network.

DOI10.1016/j.cell.2016.01.009
Alternate JournalCell
PubMed ID26898331
PubMed Central IDPMC4801341
Grant ListT32 CA160001 / CA / NCI NIH HHS / United States
T32GM007739 / GM / NIGMS NIH HHS / United States
P30 CA008748 / CA / NCI NIH HHS / United States
R01 CA034610 / CA / NCI NIH HHS / United States
P30-CA008748 / CA / NCI NIH HHS / United States
T32 GM007739 / GM / NIGMS NIH HHS / United States
R01-CA34610 / CA / NCI NIH HHS / United States

Person Type: